Peter Traber
Directeur/Membre du Conseil chez Baylor College of Medicine
Fortune : 110 791 $ au 30/04/2024
Postes actifs de Peter Traber
Sociétés | Poste | Début | Fin |
---|---|---|---|
Baylor College of Medicine | Directeur/Membre du Conseil | 01/01/2008 | - |
Directeur Général | 01/01/2003 | 01/01/2008 |
Historique de carrière de Peter Traber
Anciens postes connus de Peter Traber
Sociétés | Poste | Début | Fin |
---|---|---|---|
CARTESIAN THERAPEUTICS, INC. | Directeur Technique/Scientifique/R&D | 30/03/2020 | 13/11/2023 |
Alacrita Consulting Ltd. | Corporate Officer/Principal | 01/07/2018 | 01/08/2020 |
GALECTIN THERAPEUTICS INC. | Directeur/Membre du Conseil | 12/02/2009 | 14/12/2017 |
Directeur Général | 23/03/2011 | 06/07/2018 | |
Directeur Technique/Scientifique/R&D | 18/06/2010 | 06/07/2018 | |
Investor Relations Contact | 12/02/2009 | - | |
President | 23/03/2011 | 06/07/2018 | |
Tanox, Inc.
Tanox, Inc. Pharmaceuticals: MajorHealth Technology Tanox, Inc engages in the discovery and development of therapeutic monoclonal antibodies in the areas of asthma, allergy, inflammation, other diseases affecting the human immune system, and infectious diseases. Its product, Xolair (omalizumab), is used for treatment of adults and adolescents with moderate-to-severe persistent asthma | Directeur/Membre du Conseil | - | 03/08/2007 |
GSK PLC | Directeur Technique/Scientifique/R&D | 01/01/2000 | 01/01/2003 |
Conseiller Juridique Général | 01/01/2000 | 01/01/2003 | |
Morphic Therapeutic, Inc.
Morphic Therapeutic, Inc. BiotechnologyHealth Technology Morphic Therapeutic, Inc. engages in biotechnology drug development activity. The company is headquartered in Waltham, MA. | Directeur Technique/Scientifique/R&D | - | - |
University of Pennsylvania Medical Center | Corporate Officer/Principal | - | - |
Caladrius Biosciences, Inc.
Caladrius Biosciences, Inc. BiotechnologyHealth Technology Caladrius Biosciences, Inc. is a biopharmaceutical company, which engages in development of cell therapies for select cardiovascular and autoimmune diseases. Its product pipeline includes XOWNA, CLBS12, CLBS201 and CLBS14. The company was founded on September 18, 1980 and is headquartered in Basking Ridge, NJ. | Directeur/Membre du Conseil | 22/01/2015 | - |
Independent Dir/Board Member | 22/01/2015 | - | |
░░░ ░░░░░░░░░░ ░░ ░░░░░░░░░░░░ ░░░░░░ ░░░░░░ | ░░░░░░░░░ | - | - |
░░░░░░░░ ░░░ | ░░░░░░░░ | ░░░░░░░░░░ | - |
░░░░░░░░░ | ░░░░░░░░░░ | - | |
░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | - |
Formation de Peter Traber
University of Michigan | Undergraduate Degree |
The Wayne State University School of Medicine | Doctorate Degree |
Statistiques
Internationale
Etats-Unis | 13 |
Royaume-Uni | 3 |
Opérationnelle
Director/Board Member | 5 |
Chief Tech/Sci/R&D Officer | 4 |
President | 3 |
Sectorielle
Health Technology | 7 |
Consumer Services | 5 |
Producer Manufacturing | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 2 |
---|---|
GALECTIN THERAPEUTICS INC. | Health Technology |
GSK PLC | Health Technology |
Entreprise privées | 8 |
---|---|
Tanox, Inc.
Tanox, Inc. Pharmaceuticals: MajorHealth Technology Tanox, Inc engages in the discovery and development of therapeutic monoclonal antibodies in the areas of asthma, allergy, inflammation, other diseases affecting the human immune system, and infectious diseases. Its product, Xolair (omalizumab), is used for treatment of adults and adolescents with moderate-to-severe persistent asthma | Health Technology |
Noble International Ltd.
Noble International Ltd. Auto Parts: OEMProducer Manufacturing Noble International Ltd. manufactures and supplies automotive components, provides laser welding and cutting services. The company is headquartered in Troy, MI. | Producer Manufacturing |
Terrasep LLC | |
The University of Pennsylvania Health System
The University of Pennsylvania Health System Miscellaneous Commercial ServicesCommercial Services The University of Pennsylvania Health System provides general patient care as well as medical education and research services. The company was founded in 1874 and is headquartered in Philadelphia, PA. | Commercial Services |
Caladrius Biosciences, Inc.
Caladrius Biosciences, Inc. BiotechnologyHealth Technology Caladrius Biosciences, Inc. is a biopharmaceutical company, which engages in development of cell therapies for select cardiovascular and autoimmune diseases. Its product pipeline includes XOWNA, CLBS12, CLBS201 and CLBS14. The company was founded on September 18, 1980 and is headquartered in Basking Ridge, NJ. | Health Technology |
Selecta Biosciences, Inc.
Selecta Biosciences, Inc. BiotechnologyHealth Technology Selecta Biosciences, Inc. is a clinical-stage biopharmaceutical company, which engages in the research and development of nanoparticle immunomodulatory drugs for the treatment and prevention of human diseases. Its portfolio includes pipeline, autoimmune, gene therapy, and biologic therapy. The company was founded by Omid C. Farokhzad, Robert S. Langer Jr., and Ulrich von Andrian on December 10, 2007 and is headquartered in Watertown, MA. | Health Technology |
Alacrita Consulting Ltd. | |
Morphic Therapeutic, Inc.
Morphic Therapeutic, Inc. BiotechnologyHealth Technology Morphic Therapeutic, Inc. engages in biotechnology drug development activity. The company is headquartered in Waltham, MA. | Health Technology |
- Bourse
- Insiders
- Peter Traber
- Expérience